PMEA was found to influence the immune system of the mouse and rat in
vivo in different ways. PMEA administered after injection of parental
splenocytes to F-1 recipients reduced the development of local graft-v
ersus-host reaction (GVHR). However, PMEA treatment of donors of splen
ocytes had no influence on GVHR. Modifications in the immune system tr
iggered by PMEA were confirmed in the rat model by evaluation of subse
ts of white blood cells isolated from peripheral blood by a set of mon
oclonal antibodies. Enhanced formation of nitric oxide (NO) was found
in both unconditioned and LPS-stimulated macrophage cultures on day 14
of the drug treatment of rats.